| PMID | Titre | Auteurs | Année | Journal |
| 30791615 | IRES Trans-Acting Factors, Key Actors of the Stress Response. | Godet AC, David F, Hantelys F, Tatin F, Lacazette E, Garmy-Susini B, Prats AC. | 2019 | Int J Mol Sci |
| 30650064 | Hormone therapy outcome in lymphedema | Garmy-Susini B. | 2019 | Aging |
| 31815666 | Vasohibin1, a new mouse cardiomyocyte IRES trans-acting factor that regulates translation during early hypoxia. | Hantelys F, Godet AC, David F, Tatin F, Renaud-Gabardos E, Pujol F, Diallo LH, Ader I, Ligat L, Henras AK, Sato Y, Parini A, Lacazette E, Garmy-Susini B, Prats AC. | 2019 | Elife |
| 31863036 | Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis | Audrey Zamora1, Melinda Alves1, Charlotte Chollet2, Nicole Therville3, Tiffany Fougeray4, Florence Tatin1, Camille Franchet5, Anne Gomez-Brouchet5, Charlotte Vaysse2, Laurent O. Martinez1, Souad Najib | 2019 | Cell Death Dis |
| 29650694 | Lymphatic vasculature requires estrogen receptor alpha signaling to protect from lymphedema. | Morfoisse F. PhD1*, Tatin F. PhD 1*, Chapût B. MD2, ...Prats AC. PhD 1, Guillermet-Guibert J. PhD 3, Lenfant F. PhD 1, Garmy-Susini B. PhD | 2018 | Arterioscler Thromb Vasc Biol. |
| 29249393 | Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart. | Renaud-Gabardos E, Tatin F, Hantelys F, Lebas B, Calise D, Kunduzova O, Masri B, Pujol F, Sicard P, Valet P, Roncalli J, Chaufour X, Garmy-Susini B, Parini A, Prats AC. | 2018 | Mol Ther. |
| 27903483 | Therapeutic Benefits and Adverse Effects of Combined Pro-Angiogenic Gene Therapy in Mouse Critical Leg Ischemia. | Lebas B, Galley J, Renaud-Gabardos E, Pujol F, Lenfant F, Garmy-Susini B, Chaufour X, Prats AC. | 2017 | Ann Vasc Surg. |
| 28705793 | Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis | Pujol F1, Hodgson T1, Martinez-Corral I1, Prats AC1, Devenport D1, Takeichi M1, Genot E1, Mäkinen T1, Francis-West P1, Garmy-Susini B1, Tatin F2. | 2017 | Arterioscler Thromb Vasc Biol |
| 28614788 | Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction | Tatin F1, Renaud-Gabardos E1, Godet AC1, Hantelys F1, Pujol F1, Morfoisse F1, Calise D2, Viars F3, Valet P1, Masri B, Prats AC1, Garmy-Susini B. | 2017 | JCI Insight |
| 28499274 | Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome | Basset C1,2, Bonnet-Magnaval F3, Navarro MG3, Touriol C1, Courtade M1,2, Prats H1, Garmy-Susini B, Lacazette E. | 2017 | Oncotarget |
| 27280395 | Nucleolin Promotes Heat Shock-Associated Translation of VEGF-D to Promote Tumor Lymphangiogenesis. | Morfoisse F, Tatin F, Hantelys F, Adoue A, Helfer AC, Cassant-Sourdy S, Pujol F, Gomez-Brouchet A, Ligat L, Lopez F, Pyronnet S, Courty J, Guillermet-Guibert J, Marzi S, Schneider RJ, Prats AC, Garmy- | 2016 | Cancer Res. |
| 27308508 | Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis. | Morfoisse F, Renaud E, Hantelys F, Prats AC, Garmy-Susini B. | 2015 | Mol Cell Oncol |
| 26332123 | Promoter-Dependent Translation Controlled by p54nrb and hnRNPM during Myoblast Differentiation. | Ainaoui N, Hantelys F, Renaud-Gabardos E, Bunel M, Lopez F, Pujol F, Planes R, Bahraoui E, Pichereaux C, Burlet-Schiltz O, Parini A, Garmy-Susini B, Prats AC. | 2015 | PLoS One. |
| 26322231 | Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation. | Brahimi-Horn MC, Giuliano S, Saland E, Lacas-Gervais S, Sheiko T, Pelletier J, Bourget I, Bost F, Féral C, Boulter E, Tauc M, Ivan M, Garmy-Susini B, Popa A, Mari B, Sarry JE, Craigen WJ, Pouys | 2015 | Cancer Metab. |
| 25699230 | Internal ribosome entry site-based vectors for combined gene therapy. | Renaud-Gabardos E, Hantelys F, Morfoisse F, Chaufour X, Garmy-Susini B, Prats AC. | 2015 | World J Exp Med. |
| 25176316 | Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody. | Camaré C, Trayssac M, Garmy-Susini B, Mucher E, Sabbadini R, Salvayre R, Negre-Salvayre A. | 2015 | Br J Pharmacol. |
| 25452273 | Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α. | Baer R, Cintas C, Dufresne M, Cassant-Sourdy S, Schönhuber N, Planque L, Lulka H, Couderc B, Bousquet C, Garmy-Susini B, Vanhaesebroeck B, Pyronnet S, Saur D, Guillermet-Guibert J. | 2014 | Genes Dev. |
| 24939534 | [Lymphangiogenic gene expression adaptation in tumor hypoxic environment]. | Morfoisse F, Renaud E, Hantelys F, Prats AC, Garmy-Susini B. | 2014 | Med Sci |
| 24388748 | Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-independent translation-mediated mechanism. | Morfoisse F, Kuchnio A, Frainay C, Gomez-Brouchet A, Delisle MB, Marzi S, Helfer AC, Hantelys F, Pujol F, Guillermet-Guibert J, Bousquet C, Dewerchin M, Pyronnet S, Prats AC, Carmeliet P, Garmy-Susini | 2014 | Cell Rep. |
| 23671068 | PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes. | Garmy-Susini B, Avraamides CJ, Desgrosellier JS, Schmid MC, Foubert P, Ellies LG, Lowy AM, Blair SL, Vandenberg SR, Datnow B, Wang HY, Cheresh DA, Varner J. | 2013 | Proc Natl Acad Sci U S A. |
| 18497750 | Integrins in angiogenesis and lymphangiogenesis. | Avraamides CJ, Garmy-Susini B, Varner JA. | 2008 | Nat Rev Cancer. |
